U.S. Markets open in 13 hrs, 16 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.95 | 132.79 | 1.29% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.24 | 14.86 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.25 10:39 AM EST | |
|---|---|---|
| Day High | 2.36 09:30 AM EST |
|
| Range | 0.11 |
| Volume | 376,041 | |
|---|---|---|
| 30-Day Avg Vol | 883,000 |
|
| Difference | -57.41% |
| Market Cap | 128.19 M | |
|---|---|---|
| Mkt Cap Chg | -559,805 |
| Shares Out | 55.98 M | |
|---|---|---|
| % Shrs Traded | 0.67% | |
| 1yr EPS Est | -0.265 |
| 52-Wk Low | 0.09 | |
|---|---|---|
| 52-Wk High | 3.33 |
|
| Range | 3.24 |
| Prev Close | 2.30 11/20/09 | |
|---|---|---|
| Today's Open | 2.35 | |
| Change | 2.17% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 762,912.00 |
| Revenue (LFY) | 1.28 M | |
|---|---|---|
| Earnings (LFY) | -52.88 M | |
| Earnings (MRQ) | 560,000.00 | |
| Next Earn Est | -0.065 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | 0.23 | |
| 1yr EPS Growth | -215.22% |
| P/E Ratio (TTM) | 9.16 | |
|---|---|---|
| P/E Ratio (Fwd) | -8.00 | |
| PEG Ratio | — | |
| Return on Equity | -239.37 | |
| Beta | 3.59 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Drugs are a life-or-death business for Keryx Biopharmaceuticals. The company specializes in developing treatments for life-threatening ailments, such as cancer and kidney disease. Its lead candidate is ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.065 3/8/10 | — — |
—
—
|
| Last Quarter | -0.085 9/30/09 | 0.01 9/30/09 |
0.095
Beat
|
| 2 Quarters Ago | -0.075 6/30/09 | 0.29 6/30/09 |
0.365
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.50 M | 1.28 M |
| Gross Profit | 3.48 M | 1.14 M |
| Operating Income | 431,000.00 | -38.79 M |
| Net Income | 560,000.00 | -52.88 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts